Huifeng has been increasing their inventory of Diosmin in anticipation of COS approval and expects to be able to begin shipments to Safic-Alcan in the fall.
Diosmin is a flavonoid that can be isolated from various plant sources or derived from the flavonoid hesperidin. Diosmin is used as a pharmaceutical material as a supplement to treat chronic venous insufficiency, hemorrhoids, lymphedema, and varicose veins.
About Huifeng Bio-Pharmaceutical Technology, Inc.
Huifeng Bio-Pharmaceutical Technology, Inc., located in Xi'an, People's Republic of China, develops and produces plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production. It is the leading Chinese producer of rutin and related plant-derived chemicals in a class called flavonoids, with medicinal and other beneficial properties. Founded in 2002, Huifeng uses proprietary patented processes to extract rutin more efficiently than traditional extraction techniques. The Company is diversifying its product lines through internal development, acquisition and cooperation with scientific research organizations. More information can be found on the company's web site at: http://www.hfgb.cn/
Forward-Looking Statement Notice:
This press release includes "forward-looking statements" as defined by
the Securities and Exchange Commission (the "SEC"), including statements
regarding COS certification and shipments of products. All statements,
other than statements of historical fact, included in the press release
that address activities, events or developments that the company believes
or anticipates will or may occur in the future are forward- looking
statements. These statements are based on certain assumptions made based on
experience, expected future developments and other factors
|SOURCE Huifeng Bio-Pharmaceutical Technology, Inc.|
Copyright©2008 PR Newswire.
All rights reserved